Study of the Efficacy, Safety and Tolerability of Topical 2PX (Strontium Chloride Hexahydrate) in Patients With Chronic, Moderate-to-Severe Lower Limb Post-Amputation Stump Pain.

Trial Profile

Study of the Efficacy, Safety and Tolerability of Topical 2PX (Strontium Chloride Hexahydrate) in Patients With Chronic, Moderate-to-Severe Lower Limb Post-Amputation Stump Pain.

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs 2 PX (Primary)
  • Indications Neuropathic pain; Phantom limb pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Aug 2010 Status changed from recruiting to completed, as reported by the European Clinical Trials Database.
    • 25 Mar 2010 Planned end date changed from Apr 2010 to Jun 2010 as reported by ClinicalTrials.gov.
    • 12 Dec 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top